| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j2023M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0102023 |
| P932 | PMC publication ID | 4096762 |
| P698 | PubMed publication ID | 25019523 |
| P5875 | ResearchGate publication ID | 263899348 |
| P50 | author | Sam Salman | Q55175927 |
| Timothy M Davis | Q56599346 | ||
| Laurens Manning | Q82520587 | ||
| Paul R Ingram | Q118397129 | ||
| P2093 | author name string | John Dyer | |
| Cameron Wright | |||
| Christopher H Heath | |||
| Madhu Page-Sharp | |||
| Timothy J Whitmore | |||
| Ingrid Manson | |||
| P2860 | cites work | Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units) | Q34111057 |
| Pharmacokinetic and pharmacodynamic properties of meropenem | Q37247125 | ||
| Guidelines for the practical stability studies of anticancer drugs: a European consensus conference | Q37917214 | ||
| Stability of meropenem in normal saline solution after storage at room temperature. | Q39102103 | ||
| Incidence of Neutropenia during Treatment of Bone-Related Infections with Piperacillin-Tazobactam | Q40546181 | ||
| Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis | Q41063056 | ||
| Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital | Q42245030 | ||
| Stability of meropenem and doripenem solutions for administration by continuous infusion | Q43153667 | ||
| Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison | Q43609117 | ||
| Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis | Q44930989 | ||
| Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy | Q45107382 | ||
| Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device | Q45148437 | ||
| Thermal and alkaline stability of meropenem: degradation products and cytotoxicity | Q46975470 | ||
| Stability of meropenem in intravenous solutions | Q73096192 | ||
| Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines | Q80265889 | ||
| Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients | Q80305667 | ||
| Neutropenia is rare in patients receiving continuous infusions of vancomycin in an Australian Hospital in the Home setting | Q87207653 | ||
| Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures | Q87459116 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meropenem | Q421670 |
| P304 | page(s) | e102023 | |
| P577 | publication date | 2014-07-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability | |
| P478 | volume | 9 |
| Q92855882 | An investigation of the stability of meropenem in elastomeric infusion devices |
| Q41097970 | Chemical Stability of Ceftolozane/Tazobactam in Polyvinylchloride Bags and Elastomeric Pumps |
| Q91974118 | Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting |
| Q38693420 | Pharmacokinetic/Pharmacodynamic Analysis of Meropenem for the Treatment of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients by Monte Carlo Simulation |
| Q41349399 | Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial in |
| Q40069462 | Stability of Ertapenem 100 mg/mL in Manufacturer's Glass Vials or Syringes at 4°C and 23°C. |
| Q46270875 | Successful outpatient parenteral antibiotic therapy delivery via telemedicine |
| Q89536643 | Suitability of Amoxicillin-Clavulanic Acid for Administration via Prolonged Infusion |
| Q42101866 | Tigecycline use in the outpatient parenteral antibiotic therapy setting. |
| Q57815074 | Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion |
Search more.